Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neurophysiologic changes during estrogen augmentation in perimenopausal depression.

Melinda L Morgan1, Ian A Cook, Andrea J Rapkin

  • 1Laboratory of Brain, Behavior, and Pharmacology, Department of Psychiatry and Biobehavioral Sciences, UCLA Neuropsychiatric Institute, 760 Westwood Plaza, Suite 37-439, Los Angeles, CA 90024-1759, United States. melinda@ucla.edu

Maturitas
|July 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world evidence of SAINT® effectiveness in a heterogenous clinical population with psychiatric and medical comorbidities: A multicenter, open-label, community-based study.

Journal of mood and anxiety disorders·2026
Same author

Ventrolateral prefrontal-amygdala repetitive transcranial magnetic stimulation (rTMS) modulation of impulsivity in borderline personality disorder: a proof-of-concept study.

Scientific reports·2026
Same author

Factors associated with treatment-emergent headache occurrence following RTMS to non-motor areas and the impact on treatment outcomes: a retrospective study.

Frontiers in psychiatry·2026
Same author

Effects of theta burst stimulation on neural connectivity and visual perception following attention modification of own-face viewing in body dysmorphic disorder.

medRxiv : the preprint server for health sciences·2026
Same author

A cell type-specific mechanism driving the rapid antidepressant effects of transcranial magnetic stimulation.

Cell·2026
Same author

The relationship between individual alpha-band activity and cognitive outcomes from repetitive Transcranial Magnetic Stimulation (rTMS) treatment for Major Depressive Disorder (MDD).

Journal of affective disorders·2026
Same journal

Urinary and vaginal symptoms in postmenopausal women: a cross-sectional online survey of Greek women.

Maturitas·2026
Same journal

Association between TyG-FI and depressive symptom trajectories in middle-aged and older adults: interaction with cognitive function and mediation analysis of sleep quality.

Maturitas·2026
Same journal

Intrinsic capacity and the trajectory of ischemic heart disease and its complications: the mediating role of insulin resistance indices.

Maturitas·2026
Same journal

Mobility limitation trajectories and longitudinal changes in delayed recall in midlife and later life: A multicohort study.

Maturitas·2026
Same journal

Digital twins in menopause: a roadmap for integrating endocrine dynamics, multisystem physiology, and precision medicine.

Maturitas·2026
Same journal

Testosterone therapy in women: Keeping pace with the evidence.

Maturitas·2026
See all related articles

Estrogen therapy improved perimenopausal depression by altering brain activity. Specifically, remission in depression correlated with reduced right frontal brain activity (QEEG cordance) after estrogen treatment.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Psychiatry

Background:

  • Perimenopausal depression affects many women, with estrogen augmentation showing promise alongside antidepressants.
  • Estrogen's role in mood regulation is linked to its facilitation of serotonergic transmission in key brain regions.
  • Understanding the neurophysiological changes associated with treatment response is crucial for optimizing care.

Purpose of the Study:

  • To investigate differences in brain activity using quantitative electroencephalography (QEEG) between women with perimenopausal depression who achieved remission and those who did not, following estrogen augmentation.
  • To explore correlations between serum hormone levels and observed neurophysiological changes.

Main Methods:

  • Quantitative electroencephalography (QEEG) was employed to assess neurophysiological changes.

Related Experiment Videos

  • Participants included women with major depressive disorder (MDD) in partial remission, experiencing perimenopausal symptoms and on antidepressant medication.
  • QEEG measures (absolute power, relative power, cordance) were recorded before and after a 6-week course of conjugated estrogen (0.625 mg/day).

    • Main Results:

    • Women achieving depressive symptom remission (Hamilton Depression Rating Scale score ≤7) exhibited a significant reduction in right frontal QEEG cordance.
    • This decrease in right frontal QEEG cordance was not observed in women who did not achieve remission.
    • No significant correlations were identified between serum hormone levels and QEEG cordance changes.

    Conclusions:

    • Physiologic brain changes, specifically in the right frontal region, are associated with successful remission of perimenopausal depression when treated with estrogen augmentation.
    • These findings highlight the potential of QEEG to serve as a biomarker for treatment response in this patient population.